Realta投资顾问公司将其在iShares生物技术ETF的股份削减了90.4%,而其他投资者则增加了其股份。 Realta Investment Advisors cut its stake in the iShares Biotechnology ETF by 90.4%, while other investors increased theirs.

房地产投资顾问在第四季度将其在iShares生物技术ETF(IBB)中的份额大幅降低90.4%,而其他投资者,如BNP Paribas金融市场和Appleton伙伴公司,则增加了其股份。 Realta Investment Advisors significantly reduced its shares in the iShares Biotechnology ETF (IBB) by 90.4% in the fourth quarter, while other investors like BNP Paribas Financial Markets and Appleton Partners Inc. increased their stakes. 避险基金和机构投资者现在拥有62.45%的IBB股票。 Hedge funds and institutional investors now own 62.45% of IBB's stock. ETF跟踪NASDAQ生物技术指数,最近支付了0.0624美元的红利。 The ETF tracks the NASDAQ Biotechnology Index and recently paid a dividend of $0.0624.